|
|
|
Insider
Information: |
Romano Kelly A |
Relationship: |
Director |
City: |
Colmar |
State: |
PA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
46,728 |
|
Indirect Shares
|
18,001 |
|
|
Direct
Value |
$750,692 |
|
|
Indirect Value
|
$456,865 |
|
|
Total
Shares |
64,729 |
|
|
Total
Value |
$1,207,557 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Dorman Products Inc |
DORM |
Director |
2023-06-01 |
8,413 |
2017-11-09 |
0 |
Premium* |
|
UGI Corp |
UGI |
Director |
2019-01-30 |
0 |
2024-01-26 |
18,001 |
Premium* |
|
Athira Pharma, Inc. |
ATHA |
Director |
2022-12-02 |
38,315 |
2022-03-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
UGI |
UGI Corp |
Director |
|
2024-01-26 |
4 |
A |
$0.00 |
$0 |
I/I |
4,470 |
18,001 |
0 |
- |
|
DORM |
Dorman Products Inc |
Director |
|
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,510 |
8,413 |
0 |
- |
|
DORM |
Dorman Products Inc |
Director |
|
2023-05-18 |
4 |
D |
$86.54 |
$3,289 |
D/D |
(38) |
6,903 |
0 |
- |
|
UGI |
UGI Corp |
Director |
|
2023-01-27 |
4 |
A |
$0.00 |
$0 |
I/I |
2,600 |
12,761 |
0 |
- |
|
ATHA |
Athira Pharma, Inc. |
Director |
|
2022-12-02 |
4 |
B |
$3.29 |
$98,700 |
D/D |
30,000 |
38,315 |
2.39 |
- |
|
DORM |
Dorman Products Inc |
Director |
|
2022-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,223 |
6,941 |
0 |
- |
|
DORM |
Dorman Products Inc |
Director |
|
2022-05-25 |
4 |
D |
$98.06 |
$3,236 |
D/D |
(33) |
5,718 |
0 |
- |
|
ATHA |
Athira Pharma, Inc. |
Director |
|
2022-03-31 |
4 |
B |
$13.11 |
$104,880 |
D/D |
8,000 |
8,315 |
2.39 |
- |
|
UGI |
UGI Corp |
Director |
|
2022-01-28 |
4/A |
A |
$0.00 |
$0 |
I/I |
2,300 |
9,784 |
0 |
- |
|
UGI |
UGI Corp |
Director |
|
2022-01-28 |
4 |
A |
$0.00 |
$0 |
I/I |
6,050 |
13,534 |
0 |
- |
|
DORM |
Dorman Products Inc |
Director |
|
2021-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,064 |
5,751 |
0 |
- |
|
DORM |
Dorman Products Inc |
Director |
|
2021-05-13 |
4 |
D |
$103.03 |
$4,533 |
D/D |
(44) |
4,687 |
0 |
- |
|
UGI |
UGI Corp |
Director |
|
2021-01-29 |
4 |
A |
$0.00 |
$0 |
I/I |
2,870 |
7,268 |
0 |
- |
|
DORM |
Dorman Products Inc |
Director |
|
2020-07-02 |
4 |
D |
$66.67 |
$2,400 |
D/D |
(36) |
4,731 |
0 |
- |
|
DORM |
Dorman Products Inc |
Director |
|
2020-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,429 |
4,767 |
0 |
- |
|
UGI |
UGI Corp |
Director |
|
2020-01-22 |
4 |
A |
$0.00 |
$0 |
I/I |
2,350 |
4,239 |
0 |
- |
|
DORM |
Dorman Products Inc |
Director |
|
2019-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,158 |
3,338 |
0 |
- |
|
DORM |
Dorman Products Inc |
Director |
|
2019-07-01 |
4 |
D |
$87.52 |
$3,588 |
D/D |
(41) |
2,180 |
0 |
- |
|
UGI |
UGI Corp |
Director |
|
2019-01-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,840 |
1,840 |
0 |
- |
|
DORM |
Dorman Products Inc |
Director |
|
2018-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,318 |
2,221 |
0 |
- |
|
DORM |
Dorman Products Inc |
Director |
|
2017-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
903 |
903 |
0 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|